DURECT Corp (DRRX) Misses Q4 EPS by 1c, Revenues Miss

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. SPCX
2. HUM
3. ALHC
4. PEP
5. AXP
6. T
7. TMUS
8. SPY
9. CVS
10. UNH

Go back to DURECT Corp (DRRX) Misses Q4 EPS by 1c, Revenues Miss

DURECT Corporation Announces Fourth Quarter and Full Year 2020 Financial Results and Update of Programs

March 4, 2021 4:05 PM EST

CUPERTINO, Calif., March 4, 2021 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced financial results for the three months and year ended December 31, 2020 and provided a corporate update.  

"We have achieved a number of important milestones over the past few months, most significantly, initiating dosing in the DUR-928 AHFIRM trial in patients with severe alcohol-associated hepatitis (AH) and obtaining Fast Track... More